Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

W.R. Grace & Co. (GRA), Actavis plc (ACT): Richard Chilton’s Five Largest Holdings From His Latest 13F

Page 1 of 2

Richard Chilton‘s Chilton Investment Company, LLC is a hedge fund founded in 1992 by former Alliance Capital, Merrill Lynch, and Allen & Company employee, Richard Lockwood Chilton Jr. Launched as a long-short fund, the fund has evolved to employ aggressive capital appreciation strategies in its investments, which include both public equity and fixed income markets. In 2011 the fund had $7.5 billion in assets under management, though this has since shrunk to around $3 billion. As of the end of 2014, the fund disclosed an equity portfolio valued at $2.87 billion that contains over 170 positions, mainly represented by Services Stocks. According to the latest 13F filing, Chilton’s top picks include W.R. Grace & Co. (NYSE:GRA), Sherwin-Williams Co. (NYSE:SHW), Union Pacific Corporation (NYSE:UNP), Covidien plc (NYSE:COV) and Actavis plc (NYSE:ACT).


We track hedge funds and billionaire investors because our research has shown that a portfolio that consists of the most popular small-cap stocks among these investors outperformed the S&P 500 Total Return Index by almost one percentage point per month between 1999 and 2012 in our backtests, while their 50 top picks (mostly represented by large-cap companies), underperformed the Index by around 7 basis points. We have been sharing the list of the 15 most popular small-cap stocks among hedge funds in real time since the end of August 2012. This strategy has returned around 132% since then, in comparison to a gain of only 57% for the S&P 500 ETF (SPY) during the same period (read the details here).

According to the fund’s latest 13F filing, Chilton decreased its position in the chemical specialty company W.R. Grace & Co. (NYSE:GRA) by 9% on the quarter, but the position remains the fund’s largest, constituting 6.20% of its equity portfolio. The investor owns 1.87 million shares of the company, valued at $177.95 million. Moreover, W.R. Grace’s popularity among hedge funds is something that is worth noticing, because in the latest round of 13F filings, a total of 42 investors reported holding around $3.14 billion worth of W.R. Grace & Co. (NYSE:GRA)’s stock (more than 40% of the company’s shares). At the end of December last year, Iridian Asset Management held 5.35 million shares of the company, followed by billionaires John Griffin and Stephen Mandel, as W.R. Grace & Co. (NYSE:GRA)’s three largest shareholders among the funds that we track.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!